Citius Oncology Inc.

NASDAQ:CTOR  
5.29
+0.07 (+1.34%)
4:56:53 PM EDT: $5.22 -0.07 (-1.32%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Citius Oncology Inc. Stock, NASDAQ:CTOR

11 Commerce Drive, 1st floor, Cranford, New Jersey 07016
United States of America
Phone:
Number of Employees:

Description

Citius Oncology, Inc. is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.